18721657

Brassard M

2008

Basic infertility including polycystic ovary syndrome.

18722363

M?rquez JL

2008

Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.

18722605

Kalra P

2009

Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome.

18722607

Landay M

2009

Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS.

18724527

Svacina S

2008

[Metabolic syndrome and skin diseases].

18725155

Pusalkar M

2009

CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.

18725241

Roberts CP

2008

Applications of estradiol and testosterone assays in the management of the infertile female patient.

18726694

Ib??ez L

2009

Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.

18728124

Gambineri A

2008

Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin.

18728175

Hoeger K

2008

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.

18728832

Mathur R

2008

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome.

18729532

Kodaman PH

2008

HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

18756476

Morrell MJ

2008

Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine.

18756626

Muthukrishnan J

2008

Re: Premicroalbuminuria in polycystic ovary syndrome.

18756827

Pekhlivanov B

2008

[Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].

18757445

Goodarzi MO

2008

FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.

18762242

Haddad GF

2008

Case series of rosiglitazone used during the first trimester of pregnancy.

18765011

De Sutter P

2008

PCOS in lesbian and heterosexual women treated with artificial donor insemination.

18765015

Qiao J

2008

Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome.

18768676

Goodarzi MO

2008

First evidence of genetic association between AKT2 and polycystic ovary syndrome.

18772244

Olsen CM

2008

Epithelial ovarian cancer: testing the 'androgens hypothesis'.

18773451

Chen Y

2008

Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women.

18774558

Orvieto R

2009

What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?

18775885

Son WY

2008

Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles.

18782961

Allende-Vigo MZ

2008

Women and the metabolic syndrome: an overview of its peculiarities.

18786289

Lujan ME

2008

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

18786290

Rajput R

2008

Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature.

18787381

Erdogan M

2008

The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients.

18787386

Vrtovec B

2008

Testosterone-related shortening of QTc interval in women with polycystic ovary syndrome.

18790681

Tanriover MD

2009

Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment?

18792416

Rousset P

2008

Ovarian hyperthecosis on grayscale and color Doppler ultrasound.

18794162

Amer SA

2009

Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome.

18795969

Soares GM

2009

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome.

18799960

Giallauria F

2008

Cardiovascular risk in women with polycystic ovary syndrome.

18802744

Kurzawa R

2008

Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.

18803938

Asagami T

2008

Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

18803944

Cheang KI

2008

Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.

18804205

Tamura H

2009

Melatonin and the ovary: physiological and pathophysiological implications.

18804337

Walch K

2008

Polymorphisms of the endothelial nitric oxide synthase gene in premenopausal women with polycystic ovary syndrome.

18805020

Broekmans FJ

2008

Anti-M?llerian hormone and ovarian dysfunction.

18812422

Requena A

2008

Use of letrozole in assisted reproduction: a systematic review and meta-analysis.

18812482

Rossi B

2008

Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.

18812636

Zwirska-Korczala K

2008

Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.

18817896

Elia E

2008

Detrimental effects of hyperandrogenism on uterine functions.

18819057

Pall ME

2008

Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

18827957

Andreou C

2008

Metformine for psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome.

18829008

Rochester D

2009

Partial recovery of luteal function after bariatric surgery in obese women.

18829900

Mlinar B

2008

Decreased lipin 1 beta expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome.

18832802

Moret M

2009

Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients.

18834342

Nawaz FH

2008

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

18838418

Shield JP

2009

Management and 1 year outcome for UK children with type 2 diabetes.

18840925

Goto J

2009

Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly.

18843833

Drown DJ

2008

Metformin: effective in the prevention of new-onset type 2 diabetes?

18843962

Shi YH

2008

[Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].

18844711

Blume-Peytavi U

2008

Medical treatment of hirsutism.

18844713

Rosenfield RL

2008

What every physician should know about polycystic ovary syndrome.

18844715

Somani N

2008

The clinical evaluation of hirsutism.

18848173

Panidis D

2008

Plasma visfatin levels in normal weight women with polycystic ovary syndrome.

18850378

Amini M

2008

Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.

18850379

Cosar E

2008

Body fat composition and distribution in women with polycystic ovary syndrome.

18851710

Moran LJ

2009

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.

18851848

Lam PM

2009

Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome.

18854391

Ciaraldi TP

2009

Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

18854405

Kevenaar ME

2009

Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.

18854802

Unfer V

2008

[Treatment of hyperandrogenism and hyperinsulinemia in PCOS patients with essential amino acids. A pilot clinical study].

18908359

SCHNIEDER RW

1947

Sclerocystic ovaries associated with correctable sterility and oligomenorrhea.

18923160

Dorfman M

2009

Chronic-intermittent cold stress in rats induces selective ovarian insulin resistance.

18925472

Jones GL

2008

Health-related quality of life in PCOS and related infertility: how can we assess this?

18927072

Nieuwenhuis-Ruifrok AE

2009

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.

18929049

Crain DA

2008

Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.

18929079

Bauer J

2008

Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome.

18930208

Kotsa K

2009

Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome.

18937076

Liu Q

2008

The association of TAAAAn repeat polymorphism in sex hormone-binding protein gene with polycystic ovary syndrome in Chinese population.

18937712

Bideci A

2008

Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.

18937939

Palomba S

2009

Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

18940877

Sathyapalan T

2009

The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.

18946782

Vgontzas AN

2008

Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?

18948400

Frolova A

2009

Facilitative glucose transporter type 1 is differentially regulated by progesterone and estrogen in murine and human endometrial stromal cells.

18948700

Pourabolghasem S

2009

Polycystic ovary syndrome and migraine headache, is there any correlation?

18950759

Azziz R

2009

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

18951329

Toloubeydokhti T

2008

Potential regulatory functions of microRNAs in the ovary.

18952851

Doi SA

2008

Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

18956263

Jedel E

2008

Assessment of health-related quality of life: Swedish version of polycystic ovary syndrome questionnaire.

18956264

Wiksten-Almstr?mer M

2008

Prospective follow-up of menstrual disorders in adolescence and prognostic factors.

18956500

Huang LY

2008

[Polycystic ovary syndrome treated by Bu Shen Hui Yu Tang--report of 40 cases].

18957343

Taieb J

2008

[Two immunoassays for antimullerian hormone measurement: analytical and clinical performances].

18957615

Piouka A

2009

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.

18958766

Christopoulos P

2008

Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.

18958767

Karakurt F

2008

Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.

18959173

Cetkovi? A

2008

[Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction].

18971896

Pizzo A

2008

[Low-dose flutamide in the treatment of hyperandrogenism in adolescents].

18973428

Shokeir T

2008

Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.

18973889

Sa?s?z N

2009

The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.

18973900

Mains L

2009

Sextuplets: an unusual complication of single embryo transfer.

18974266

Steckler TL

2009

Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome.

18976752

Rizzo M

2009

Long-term consequences of polycystic ovary syndrome on cardiovascular risk.

18976759

Kaya C

2009

Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome.

18980763

Liou TH

2009

Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.

18984667

Aroda VR

2009

Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

18985872

Pekhlivanov B

2005

[Use of rosiglitazone in women with polycystic ovarian syndrome].